Ambulatory Treatments for RAAS Inhibitor–Related Hyperkalemia and the 1-Year Risk of Recurrence

BACKGROUND AND OBJECTIVE: The optimal ambulatory management of renin-angiotensin-aldosterone system inhibitor (RAASi)–related hyperkalemia to reduce the risk of recurrence is unknown. We examined the risk of hyperkalemia recurrence on the basis of outpatient pharmacologic changes following an episod...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin J Am Soc Nephrol
Hauptverfasser: Hundemer, Gregory L., Talarico, Robert, Tangri, Navdeep, Leon, Silvia J., Bota, Sarah E., Rhodes, Emily, Knoll, Greg A., Sood, Manish M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Nephrology 2021
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8011018/
https://ncbi.nlm.nih.gov/pubmed/33608262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.12990820
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge